NeuBase Therapeutics Inc (NBSE)
Market Closed
10 May, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
0. 38
-0.01
-1.5625%
$
1.42M Market Cap
- P/E Ratio
- Div Yield
89,703 Volume
0 Eps
$ 0.38
Previous Close 
Want to track NBSE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
NBSE Earnings Reports FAQ
What is the earnings per share (EPS) for NBSE?
The current EPS is 0.
What is the company's earnings growth rate?
NeuBase Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
NeuBase Therapeutics Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for NeuBase Therapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for NBSE at this time, as NeuBase Therapeutics Inc has no recent EPS data to calculate it.
